Your browser doesn't support javascript.
loading
Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non­radical resection: A real­world study.
Feng, Feiling; Cheng, Qingbao; Zhang, Dadong; Li, Bin; Qin, Hao; Xu, Chang; Han, Miao; Yu, Yong; Li, Zhizhen; Li, Jing-Yu; Qiu, Zhiquan; Xiong, Lei; Liu, Chen; Li, Fugen; Yi, Bin; Jiang, Xiaoqing.
Afiliación
  • Feng F; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Cheng Q; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Zhang D; Research and Development Institute of Precision Medicine, 3D Medicines Inc., Shanghai 201114, P.R. China.
  • Li B; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Qin H; Research and Development Institute of Precision Medicine, 3D Medicines Inc., Shanghai 201114, P.R. China.
  • Xu C; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Han M; Research and Development Institute of Precision Medicine, 3D Medicines Inc., Shanghai 201114, P.R. China.
  • Yu Y; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Li Z; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Li JY; Research and Development Institute of Precision Medicine, 3D Medicines Inc., Shanghai 201114, P.R. China.
  • Qiu Z; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Xiong L; Research and Development Institute of Precision Medicine, 3D Medicines Inc., Shanghai 201114, P.R. China.
  • Liu C; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Li F; Research and Development Institute of Precision Medicine, 3D Medicines Inc., Shanghai 201114, P.R. China.
  • Yi B; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
  • Jiang X; Department of Biliary I, Shanghai Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, P.R. China.
Oncol Rep ; 43(4): 1089-1102, 2020 04.
Article en En | MEDLINE | ID: mdl-32323774
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Genes Relacionados con las Neoplasias / Terapia Molecular Dirigida / Secuenciación de Nucleótidos de Alto Rendimiento / Mutación Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Genes Relacionados con las Neoplasias / Terapia Molecular Dirigida / Secuenciación de Nucleótidos de Alto Rendimiento / Mutación Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncol Rep Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article